Reaction

Stoma Site Discharge reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,706 reports · 33 co-occurring drugs

As of the last recalculation, Stoma Site Discharge appears in 2,706 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is CARBIDOPA AND LEVODOPA (PRR 128.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Carbidopa And Levodopa613128.2129.9
Rotigotine15688.088.9
Rivastigmine18982.983.7
Rasagiline Mesylate9568.068.6
Ropinirole12666.266.7
Levodopa8757.257.6
Amantadine10554.354.6
Pramipexole9448.849.1
Teduglutide3822.022.0
Donepezil Hydrochloride6113.113.1
Memantine2313.013.1
Memantine Hydrochloride2313.013.1
Melatonin7410.710.7
Clozapine15810.210.2
Lactulose5010.210.2
Lubiprostone129.89.8
Oxazepam259.09.0
Mirabegron397.97.9
Bisacodyl147.77.7
Mirtazapine857.37.3
Sennosides277.07.0
Clonazepam1366.86.8
Bisacodyl Suppositories116.66.6
Magnesium676.46.4
Quetiapine1516.36.3
Escitslopram435.85.8
Miconazole Nitrate65.35.3
Zonisamide94.74.7
Linaclotide164.64.6
Droxidopa124.34.3
Suvorexant63.63.6
Pimavanserin Tartrate243.43.4
Risankizumab-Rzaa262.52.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.